Bedoya-Toro Munera Maria E 4

What Happened Maria E. Bedoya-Toro, Senior VP of Regulatory Affairs at Dermata Therapeutics (DRMA), acquired 1,000 shares in an open-market purchase on February 17, 2026. The shares were bought at $1.27 per share for a total transaction value of $1,270. This was a purchase (code P), which investors often view as a more informative signal than routine sales.

Key Details

• Transaction date: 2026-02-17
• Price and size: 1,000 shares at $1.27 per share; total $1,270
• Transaction type/code: Open-market purchase (P)
• Filing date: Form 4 filed 2026-03-17 (marked late) — timeliness flag L
• Shares owned after transaction: Not specified in this filing
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other footnotes disclosed in the reported transaction

Context Purchases by officers are typically noted by retail investors as a potentially bullish signal, but they are only one data point and do not prove future performance. The late filing reduces the timeliness of the disclosure; Form 4s are generally due within two business days of the transaction.